| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 273,552 | 304,456 | 285,908 | | Cost of Revenue | 207,594 | 217,332 | 201,577 | | | Gross Profit | 65,958 | 87,124 | 84,331 | | | Operating Expenses | | Research Development | 19,931 | 21,124 | 20,105 | | Selling General and Administrative | 39,613 | 42,093 | 44,134 | | Non Recurring | 6,440 | (12,957) | (29,435) | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (26) | 36,864 | 49,527 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,354 | (1,041) | (268) | | Earnings Before Interest And Taxes | 5,328 | 35,823 | 49,259 | | Interest Expense | 1,764 | 1,844 | 1,020 | | Income Before Tax | 3,564 | 33,979 | 48,239 | | Income Tax Expense | 6,913 | 10,690 | 18,020 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,349) | 23,289 | 30,219 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (3,349) | 23,289 | 30,219 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,349) | $23,289 | $30,219 |
|
0.49% Nasdaq 
Income Statement
